The case for a resounding framework for AI-biotech convergence
Lakshmy Ramakrishnan
The intersection of artificial intelligence (AI) with biotechnology has ushered in a period of innovation in healthcare. The interdisciplinary nature of AI enables it to analyse and interpret large data sets from multiple domains. In the case of the life sciences, AI-biotech convergence holds the potential to alter the landscape of diagnostics, monitoring of disease progression, precision medicine, and prediction of public health threats.